Cargando…

The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta

BACKGROUND: Lysophosphatidylcholine (LPC), an atherogenic component of oxidized low-density lipoprotein, has been shown to induce the attenuation of endothelium-dependent vascular relaxation. Although benidipine, a dihydropyridine-calcium channel blocker, is known to have endothelial protective effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Makoto, Yao, Kozo, Wada, Michihito
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710319/
https://www.ncbi.nlm.nih.gov/pubmed/19558657
http://dx.doi.org/10.1186/1423-0127-16-57
_version_ 1782169358929231872
author Takayama, Makoto
Yao, Kozo
Wada, Michihito
author_facet Takayama, Makoto
Yao, Kozo
Wada, Michihito
author_sort Takayama, Makoto
collection PubMed
description BACKGROUND: Lysophosphatidylcholine (LPC), an atherogenic component of oxidized low-density lipoprotein, has been shown to induce the attenuation of endothelium-dependent vascular relaxation. Although benidipine, a dihydropyridine-calcium channel blocker, is known to have endothelial protective effects, the effects of benidipine on LPC-induced endothelial dysfunction remain unknown. We examined the effects of benidipine on the impairment of endothelium-dependent relaxation induced by LPC. METHODS: Benidipine was administered orally to rats and aortas were then isolated. Aortic rings were treated with LPC and endothelial functions were then evaluated. Additionally, the effects of benidipine on intracellular calcium concentration ([Ca(2+)](i)) and membrane fluidity altered by LPC in primary cultured rat aortic endothelial cells were examined. [Ca(2+)](i )was measured using the fluorescent calcium indicator fura-2. Membrane fluidity was monitored by measuring fluorescence recovery after photobleaching. RESULTS: Treatment with LPC impaired endothelial function. Benidipine prevents the impairment of relaxation induced by LPC. Acetylcholine elicited an increase in [Ca(2+)](i )in fura-2 loaded endothelial cells. The increase in [Ca(2+)](i )was suppressed after exposure to LPC. Plasma membrane fluidity increased following incubation with LPC. Benidipine inhibited the LPC-induced increase in membrane fluidity and impairment of increase in [Ca(2+)](i). CONCLUSION: These results suggest that benidipine inhibited LPC-induced endothelial dysfunction by maintaining increase in [Ca(2+)](i). Benidipine possesses membrane stabilization properties in LPC-treated endothelial cells. It is speculated that the preservation of membrane fluidity by benidipine may play a role in the retainment of calcium mobilization. The present findings may provide new insights into the endothelial protective effects of benidipine.
format Text
id pubmed-2710319
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27103192009-07-15 The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta Takayama, Makoto Yao, Kozo Wada, Michihito J Biomed Sci Research BACKGROUND: Lysophosphatidylcholine (LPC), an atherogenic component of oxidized low-density lipoprotein, has been shown to induce the attenuation of endothelium-dependent vascular relaxation. Although benidipine, a dihydropyridine-calcium channel blocker, is known to have endothelial protective effects, the effects of benidipine on LPC-induced endothelial dysfunction remain unknown. We examined the effects of benidipine on the impairment of endothelium-dependent relaxation induced by LPC. METHODS: Benidipine was administered orally to rats and aortas were then isolated. Aortic rings were treated with LPC and endothelial functions were then evaluated. Additionally, the effects of benidipine on intracellular calcium concentration ([Ca(2+)](i)) and membrane fluidity altered by LPC in primary cultured rat aortic endothelial cells were examined. [Ca(2+)](i )was measured using the fluorescent calcium indicator fura-2. Membrane fluidity was monitored by measuring fluorescence recovery after photobleaching. RESULTS: Treatment with LPC impaired endothelial function. Benidipine prevents the impairment of relaxation induced by LPC. Acetylcholine elicited an increase in [Ca(2+)](i )in fura-2 loaded endothelial cells. The increase in [Ca(2+)](i )was suppressed after exposure to LPC. Plasma membrane fluidity increased following incubation with LPC. Benidipine inhibited the LPC-induced increase in membrane fluidity and impairment of increase in [Ca(2+)](i). CONCLUSION: These results suggest that benidipine inhibited LPC-induced endothelial dysfunction by maintaining increase in [Ca(2+)](i). Benidipine possesses membrane stabilization properties in LPC-treated endothelial cells. It is speculated that the preservation of membrane fluidity by benidipine may play a role in the retainment of calcium mobilization. The present findings may provide new insights into the endothelial protective effects of benidipine. BioMed Central 2009-06-26 /pmc/articles/PMC2710319/ /pubmed/19558657 http://dx.doi.org/10.1186/1423-0127-16-57 Text en Copyright © 2009 Takayama et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Takayama, Makoto
Yao, Kozo
Wada, Michihito
The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
title The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
title_full The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
title_fullStr The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
title_full_unstemmed The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
title_short The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
title_sort dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710319/
https://www.ncbi.nlm.nih.gov/pubmed/19558657
http://dx.doi.org/10.1186/1423-0127-16-57
work_keys_str_mv AT takayamamakoto thedihydropyridinecalciumchannelblockerbenidipinepreventslysophosphatidylcholineinducedendothelialdysfunctioninrataorta
AT yaokozo thedihydropyridinecalciumchannelblockerbenidipinepreventslysophosphatidylcholineinducedendothelialdysfunctioninrataorta
AT wadamichihito thedihydropyridinecalciumchannelblockerbenidipinepreventslysophosphatidylcholineinducedendothelialdysfunctioninrataorta
AT takayamamakoto dihydropyridinecalciumchannelblockerbenidipinepreventslysophosphatidylcholineinducedendothelialdysfunctioninrataorta
AT yaokozo dihydropyridinecalciumchannelblockerbenidipinepreventslysophosphatidylcholineinducedendothelialdysfunctioninrataorta
AT wadamichihito dihydropyridinecalciumchannelblockerbenidipinepreventslysophosphatidylcholineinducedendothelialdysfunctioninrataorta